Clinical Trial Update: Guo's Subclavian Artery Reconstruction: The Prospective, Multiple Center Study of WeFlow-Tbranch Stent Graft System(GUEST Study) [NA]

View source ↗

Summary

Prospective multicenter trial evaluating the WeFlow-Tbranch Stent Graft System for repairing Stanford type B aortic dissection; currently active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stanford Type Aortic Dissection

Drugs mentioned

• WeFlow-Tbranch Stent Graft System

Snippet

Sponsor: Hangzhou Endonom Medtech Co., Ltd. | Conditions: Type B Aortic Dissection | NA | Status: ACTIVE_NOT_RECRUITING